Related Experiment Videos

Porphyrin ring source can alter the outer membrane protein profile of non-typable Haemophilus influenzae

I MacIver1, T O'Reilly, M R Brown

  • 1Pharmaceutical Sciences Institute, Aston University, Birmingham.

Insights

The source of the porphyrin ring affects outer membrane protein (OMP) expression in some non-typable Haemophilus influenzae (NT H. influenzae). This change in OMP profile was observed in vitro and suggests potential in vivo alterations in the human lung.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Bacterial Pathogenesis

Background:

  • Non-typable Haemophilus influenzae (NT H. influenzae) are significant respiratory pathogens.
  • Outer membrane proteins (OMPs) play crucial roles in bacterial adaptation and host interaction.
  • The influence of nutrient availability, specifically porphyrin sources, on NT H. influenzae OMP expression is not fully understood.

Purpose of the Study:

  • To investigate the impact of different porphyrin ring sources on the OMP profile of NT H. influenzae.
  • To determine if changes in OMP expression occur in vivo.

Main Methods:

  • Culturing of NT H. influenzae strains with varying porphyrin sources (haemin vs. protoporphyrin IX).
  • Analysis of bacterial protein profiles using SDS-PAGE.
  • Immunoblotting assays using patient sera to detect antibody responses to OMPs.

Main Results:

  • Replacement of haemin with protoporphyrin IX induced changes in OMP profiles in 41% of tested NT H. influenzae strains.
  • Increased production of an 84 Kda polypeptide and novel OMPs (120 or 150 Kda) were observed.
  • Patient sera showed reactivity against these altered OMPs, confirming their antigenicity and expression in vivo.

Conclusions:

  • The porphyrin source can significantly alter the OMP phenotype of NT H. influenzae.
  • These alterations are immunogenic and suggest that NT H. influenzae can adapt its OMP expression in the human lung environment.
  • Understanding these adaptive mechanisms is crucial for developing targeted therapies against NT H. influenzae infections.

Related Concept Videos